These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22178652)

  • 21. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
    Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relaxin stimulates osteoclast differentiation and activation.
    Ferlin A; Pepe A; Facciolli A; Gianesello L; Foresta C
    Bone; 2010 Feb; 46(2):504-13. PubMed ID: 19833242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
    J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of M-CSF concentration, RANKL concentration and M-CSF preinduction on osteoclastogenesis].
    Dong W; Yu J; Qi M; Bai Y; Liang R; Chen H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Dec; 27(6):1336-40. PubMed ID: 21374990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.
    Chung YH; Chang EJ; Kim SJ; Kim HH; Kim HM; Lee SB; Ko JS
    J Periodontal Res; 2006 Aug; 41(4):288-96. PubMed ID: 16827722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling.
    Yamashita M; Otsuka F; Mukai T; Yamanaka R; Otani H; Matsumoto Y; Nakamura E; Takano M; Sada KE; Makino H
    Regul Pept; 2010 Jun; 162(1-3):99-108. PubMed ID: 20346376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of multiple osteoclast precursor populations in murine bone marrow.
    Jacquin C; Gran DE; Lee SK; Lorenzo JA; Aguila HL
    J Bone Miner Res; 2006 Jan; 21(1):67-77. PubMed ID: 16355275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A role for cell-surface CSF-1 in osteoblast-mediated osteoclastogenesis.
    Yao GQ; Sun BH; Weir EC; Insogna KL
    Calcif Tissue Int; 2002 Apr; 70(4):339-46. PubMed ID: 12004339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of mouse osteoclast K-Cl Co-transporter-1 and its role during bone resorption.
    Kajiya H; Okamoto F; Li JP; Nakao A; Okabe K
    J Bone Miner Res; 2006 Jul; 21(7):984-92. PubMed ID: 16813519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TGF-beta enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF.
    Sells Galvin RJ; Gatlin CL; Horn JW; Fuson TR
    Biochem Biophys Res Commun; 1999 Nov; 265(1):233-9. PubMed ID: 10548519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K; Kudo A
    J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of mononuclear precursors into osteoclasts on the surface of Si-substituted hydroxyapatite.
    Botelho CM; Brooks RA; Spence G; McFarlane I; Lopes MA; Best SM; Santos JD; Rushton N; Bonfield W
    J Biomed Mater Res A; 2006 Sep; 78(4):709-20. PubMed ID: 16739170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ewing sarcoma cells express RANKL and support osteoclastogenesis.
    Taylor R; Knowles HJ; Athanasou NA
    J Pathol; 2011 Oct; 225(2):195-202. PubMed ID: 21547906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct inhibitory and indirect stimulatory effects of RAGE ligand S100 on sRANKL-induced osteoclastogenesis.
    Yoshida T; Flegler A; Kozlov A; Stern PH
    J Cell Biochem; 2009 Aug; 107(5):917-25. PubMed ID: 19415676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-alpha antibody: a novel mechanism of osteoclastogenesis by IL-17.
    Yago T; Nanke Y; Ichikawa N; Kobashigawa T; Mogi M; Kamatani N; Kotake S
    J Cell Biochem; 2009 Nov; 108(4):947-55. PubMed ID: 19728295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoclastic potential of human CFU-GM: biphasic effect of GM-CSF.
    Hodge JM; Kirkland MA; Aitken CJ; Waugh CM; Myers DE; Lopez CM; Adams BE; Nicholson GC
    J Bone Miner Res; 2004 Feb; 19(2):190-9. PubMed ID: 14969388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer.
    Lau YS; Danks L; Sun SG; Fox S; Sabokbar A; Harris A; Athanasou NA
    Breast Cancer Res Treat; 2007 Sep; 105(1):7-16. PubMed ID: 17151927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors.
    Shalhoub V; Faust J; Boyle WJ; Dunstan CR; Kelley M; Kaufman S; Scully S; Van G; Lacey DL
    J Cell Biochem; 1999 Feb; 72(2):251-61. PubMed ID: 10022507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The increased in vitro osteoclastogenesis in patients with rheumatoid arthritis is due to increased percentage of precursors and decreased apoptosis - the In Vitro Osteoclast Differentiation in Arthritis (IODA) study.
    Durand M; Boire G; Komarova SV; Dixon SJ; Sims SM; Harrison RE; Nabavi N; Maria O; Manolson MF; Mizianty M; Kurgan L; de Brum-Fernandes AJ
    Bone; 2011 Mar; 48(3):588-96. PubMed ID: 20959150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway.
    Iwai K; Koike M; Ohshima S; Miyatake K; Uchiyama Y; Saeki Y; Ishii M
    J Bone Miner Res; 2007 Oct; 22(10):1612-20. PubMed ID: 17576169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.